MedTrace Logo

Clinical Effects of a Nucleotides-Supplemented Infant Formula

NCT00292812 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2007-10-23

No results posted yet for this study

Summary

The study hypothesis is that different concentrations of nucleotides' supplementation of an infant formula might affect differently growth and/or other clinical parameters in neonates.

Conditions

  • Nutritional Requirements

Interventions

DRUG

Nutritional supplementation (nucleotides)

Sponsors & Collaborators

  • Materna Laboratories

    collaborator INDUSTRY

  • Soroka University Medical Center

    lead OTHER

Principal Investigators

  • Zvi Weizman, MD · Head, Pediatric GI and Nutrition Unit

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
30 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-03-31
Completion
2007-10-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00292812 on ClinicalTrials.gov